Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo
The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
Subscribe To Our Newsletter & Stay Updated
